Sonendo Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.92
- Today's High:
- $1.04
- Open Price:
- $1.04
- 52W Low:
- $0.781
- 52W High:
- $2.95
- Prev. Close:
- $1.03
- Volume:
- 22924
Company Statistics
- Market Cap.:
- $51.11 million
- Book Value:
- 1.007
- Revenue TTM:
- $43.84 million
- Operating Margin TTM:
- -139.42%
- Gross Profit TTM:
- $10.48 million
- Profit Margin:
- -135.6%
- Return on Assets TTM:
- -39.79%
- Return on Equity TTM:
- -121.23%
Company Profile
Sonendo Inc had its IPO on 2021-10-29 under the ticker symbol SONX.
The company operates in the Healthcare sector and Medical Devices industry. Sonendo Inc has a staff strength of 244 employees.
Stock update
Shares of Sonendo Inc opened at $1.04 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.92 - $1.04, and closed at $0.92.
This is a -10.68% slip from the previous day's closing price.
A total volume of 22,924 shares were traded at the close of the day’s session.
In the last one week, shares of Sonendo Inc have slipped by -5.15%.
Sonendo Inc's Key Ratios
Sonendo Inc has a market cap of $51.11 million, indicating a price to book ratio of 1.4703 and a price to sales ratio of 2.4931.
In the last 12-months Sonendo Inc’s revenue was $43.84 million with a gross profit of $10.48 million and an EBITDA of $-59176000. The EBITDA ratio measures Sonendo Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Sonendo Inc’s operating margin was -139.42% while its return on assets stood at -39.79% with a return of equity of -121.23%.
In Q2, Sonendo Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 4.7%.
Sonendo Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.45 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sonendo Inc’s profitability.
Sonendo Inc stock is trading at a EV to sales ratio of 1.6778 and a EV to EBITDA ratio of -1.2366. Its price to sales ratio in the trailing 12-months stood at 2.4931.
Sonendo Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $104.14 million
- Total Liabilities
- $11.35 million
- Operating Cash Flow
- $9.18 million
- Capital Expenditure
- $417000
- Dividend Payout Ratio
- 0%
Sonendo Inc ended 2024 with $104.14 million in total assets and $0 in total liabilities. Its intangible assets were valued at $104.14 million while shareholder equity stood at $53.04 million.
Sonendo Inc ended 2024 with $0 in deferred long-term liabilities, $11.35 million in other current liabilities, 53000.00 in common stock, $-402155000.00 in retained earnings and $8.45 million in goodwill. Its cash balance stood at $12.57 million and cash and short-term investments were $65.89 million. The company’s total short-term debt was $1,290,000 while long-term debt stood at $37.04 million.
Sonendo Inc’s total current assets stands at $87.21 million while long-term investments were $0 and short-term investments were $53.32 million. Its net receivables were $6.31 million compared to accounts payable of $1.09 million and inventory worth $13.16 million.
In 2024, Sonendo Inc's operating cash flow was $9.18 million while its capital expenditure stood at $417000.
Comparatively, Sonendo Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.92
- 52-Week High
- $2.95
- 52-Week Low
- $0.781
- Analyst Target Price
- $3.2
Sonendo Inc stock is currently trading at $0.92 per share. It touched a 52-week high of $2.95 and a 52-week low of $2.95. Analysts tracking the stock have a 12-month average target price of $3.2.
Its 50-day moving average was $1.18 and 200-day moving average was $1.7 The short ratio stood at 10.17 indicating a short percent outstanding of 0%.
Around 1659.5% of the company’s stock are held by insiders while 6591.9% are held by institutions.
Frequently Asked Questions About Sonendo Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.